Rockefeller Capital Management
LGND icon

Rockefeller Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Rockefeller Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$121K Sell
608
-119
-16% -$23.5K ﹤0.01% 2762
2025
Q4 		$137K Sell
727
-14
-2% -$2.69K ﹤0.01% 2554
2025
Q3 		$131K Buy
+741
New +$110K ﹤0.01% 2438
2023
Q1 		– Sell
-572
Closed -$38K – 3054
2022
Q4 		$38K Sell
572
-345
-38% -$22.4K ﹤0.01% 2514
2022
Q3 		$49K Buy
917
+558
+155% +$32.8K ﹤0.01% 2355
2022
Q2 		$19K Hold
359
– – ﹤0.01% 2777
2022
Q1 		$25K Sell
359
-119
-25% -$8.63K ﹤0.01% 2623
2021
Q4 		$46K Buy
478
+157
+49% +$14.5K ﹤0.01% 2259
2021
Q3 		$27K Sell
321
-113
-26% -$8.74K ﹤0.01% 2455
2021
Q2 		$35K Hold
434
– – ﹤0.01% 2238
2021
Q1 		$40K Hold
434
– – ﹤0.01% 1982
2020
Q4 		$26K Buy
434
+121
+39% +$6.9K ﹤0.01% 1902
2020
Q3 		$17K Buy
313
+162
+107% +$11.1K ﹤0.01% 1849
2020
Q2 		$11K Sell
151
-53
-26% -$3.36K ﹤0.01% 1863
2020
Q1 		$9K Buy
204
+188
+1,175% +$10.7K ﹤0.01% 1775
2019
Q4 		$1K Buy
+16
New +$1.07K ﹤0.01% 1986
2019
Q2 		– Sell
-341
Closed -$27K – 1825
2019
Q1 		$27K Buy
341
+254
+292% +$19.2K ﹤0.01% 1124
2018
Q4 		$7K Hold
87
– – ﹤0.01% 760
2018
Q3 		$15K Hold
87
– – ﹤0.01% 534
2018
Q2 		$11K Buy
+87
New +$9.71K ﹤0.01% 586

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Rockefeller Capital Management's LGND Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Ligand Pharmaceuticals (LGND) stake by 16% in Q1 2026, selling an estimated $23.5K and leaving 608 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Rockefeller Capital Management first reported a position in LGND in Q2 2018 and has held it in 20 quarters since. The position peaked at $137K in Q4 2025. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Rockefeller Capital Management held 608 shares of Ligand Pharmaceuticals worth $121K as of Q1 2026.
  • Rockefeller Capital Management sold 119 Ligand Pharmaceuticals shares in Q1 2026, an estimated $23.5K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2762 holding.
  • Rockefeller Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2018 and has held it in 20 quarters since.
  • Rockefeller Capital Management's Ligand Pharmaceuticals position peaked at $137K in Q4 2025.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.